Network meta-analysis of comparing different dosages of potassium-competitive acid blocker with proton pump inhibitor in acid related disorders

医学 兰索拉唑 内科学 不利影响 荟萃分析 科克伦图书馆 优势比 胃肠病学 剂量 随机对照试验 质子抑制剂泵 食管炎 奥美拉唑 回流 疾病
作者
Yujiao Wang,Xiaosong Dai,Xinxing Zhang
出处
期刊:Clinical and translational gastroenterology [Lippincott Williams & Wilkins]
卷期号:15 (11): e00776-e00776 被引量:1
标识
DOI:10.14309/ctg.0000000000000776
摘要

INTRODUCTION: Potassium-competitive acid blockers have emerged as a promising treatment of acid-related disorders. However, the optimal dosage for maximizing their efficacy remains unclear. The aim of this network meta-analysis was to compare the efficacy and safety of various dosages of potassium-competitive acid blockers and proton-pump inhibitors for treating acid-related disorders. METHODS: We searched PubMed, Embase, Cochrane Library, and Web of Science from inception to July 16, 2023. Data extraction was performed independently by 2 authors. The Cochrane Risk of Bias in Randomized Trials tool (RoB 2.0) was used for bias assessment. The efficacy and safety were compared using the odds ratio with 95% confidence intervals. RESULTS: Twelve articles were included in the present meta-analysis. For gastric/duodenal ulcers, keverprazan 30 mg (K30) exhibited the highest surface under the cumulative ranking (SUCRA) value (92.8%) for healing rate. In terms of total adverse events, lansoprazole 30 mg (L30) exhibited the lowest SUCRA value (25.3%) in the treatment of gastric/duodenal ulcers. For the healing rate in erosive esophagitis, the maximum SUCRA value of vonoprazan 40 mg (V40) was 90.7% in the first subgroup (erosive esophagitis using vonoprazan, keverprazan, and lansoprazole) and the maximum SUCRA value of T50 was 72.1% in the second subgroup (erosive esophagitis using tegoprazan, fexuprazan, and esomeprazole). For the total adverse events in erosive esophagitis, L15 exhibited the lowest SUCRA value (12.2%) in the first group and E40 exhibited the lowest SUCRA value (24.4%) in the second group. DISCUSSION: K30 may be the most effective dosage for increasing the healing rate of gastric/duodenal ulcers. For erosive esophagitis, V40 and T50 may be the preferred dosages.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
欢喜丝发布了新的文献求助10
4秒前
斯文败类的应助被LL采纳,获得10
4秒前
4秒前
gyro发布了新的文献求助10
4秒前
忘忧草完成签到 ,获得积分10
5秒前
5秒前
Joker完成签到,获得积分0
5秒前
luwa关注了科研通微信公众号
6秒前
6秒前
蓝天的应助被zhailingyou采纳,获得10
6秒前
6秒前
7秒前
魔幻灵煌发布了新的文献求助10
7秒前
丘比特的应助被芯子采纳,获得10
7秒前
xcx发布了新的文献求助10
7秒前
三山三完成签到,获得积分10
8秒前
鬼豆完成签到,获得积分10
8秒前
YUAN发布了新的文献求助20
8秒前
8秒前
香蕉觅云的应助被gyro采纳,获得10
9秒前
上官若男的应助被LL采纳,获得10
9秒前
领导范儿的应助被疯狂的雯子采纳,获得10
10秒前
cockcrow完成签到,获得积分20
10秒前
10秒前
10秒前
赤川川川完成签到 ,获得积分10
11秒前
11秒前
完美世界的应助被谨慎的秋烟采纳,获得10
11秒前
bai完成签到,获得积分10
11秒前
阿尼发布了新的文献求助10
11秒前
LiWen完成签到,获得积分10
11秒前
12秒前
12秒前
可爱春天发布了新的文献求助10
12秒前
杨小坤完成签到 ,获得积分10
12秒前
12秒前
了晨发布了新的文献求助10
12秒前
dabai发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153710
求助须知:如何正确求助?哪些是违规求助? 9550475
关于积分的说明 21698625
捐赠科研通 7742521
什么是DOI,文献DOI怎么找? 3425571
关于科研通互助平台的介绍 2550735
邀请新用户注册赠送积分活动 2469211